Gainers
- Theravance Biopharma TBPH shares moved upwards by 29.8% to $11.2 during Wednesday's after-market session. At the close, Theravance Biopharma's trading volume reached 848.9K shares. This is 169.7% of its average volume over the last 100 days. The company's market cap stands at $852.4 million.
- Innoviva INVA stock moved upwards by 10.67% to $15.45. The company's market cap stands at $1.0 billion.
- Artelo Biosciences ARTL stock increased by 8.65% to $0.36. The market value of their outstanding shares is at $15.5 million.
- ThermoGenesis Holdings THMO stock increased by 7.99% to $0.22. The market value of their outstanding shares is at $2.7 million.
- aTyr Pharma LIFE shares moved upwards by 7.41% to $3.33. The company's market cap stands at $93.4 million.
- Calithera Biosciences CALA shares moved upwards by 7.4% to $2.9. The company's market cap stands at $14.0 million.
Losers
- ContraFect CFRX stock declined by 77.1% to $0.65 during Wednesday's after-market session. ContraFect's trading volume hit 3.0 million shares by close, accounting for 1922.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $25.6 million.
- Azenta AZTA stock decreased by 11.01% to $66.0. The market value of their outstanding shares is at $4.9 billion.
- Marker Therapeutics MRKR shares fell 7.2% to $0.32. The market value of their outstanding shares is at $26.7 million.
- NeuroMetrix NURO stock fell 6.32% to $3.41. The company's market cap stands at $24.3 million.
- Kiromic BioPharma KRBP shares decreased by 6.31% to $0.44. The market value of their outstanding shares is at $6.9 million.
- SELLAS Life Sciences Gr SLS shares declined by 6.26% to $2.4. The company's market cap stands at $49.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in